Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	37,592	29,316	21,731	27,358	17,834	12,344
Market Cap Growth	19.47%	34.90%	-20.57%	53.40%	44.47%	7.89%
Enterprise Value	37,633	29,263	21,965	27,663	17,475	11,967
Last Close Price	284.70	225.80	175.80	221.35	149.40	105.76
PS Ratio	13.74	13.50	13.14	28.18	24.02	30.64
PB Ratio	188.58	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	188.58	452.40	-	-	34.48	14.86
P/FCF Ratio	199.25	-	572.67	-	-	-
P/OCF Ratio	165.90	-	230.62	-	-	-
EV/Sales Ratio	13.93	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	199.47	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%
Earnings Yield	0.10%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.50%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.